NASDAQ:KZIA - Kazia Therapeutics Limited
$2.83
 $0.00
0.00%
12:20PM EDT
2019-07-22
Kazia Therapeutics Limited, formerly Novogen Limited, incorporated on March 18, 1994, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. It has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding various drug candidates across a range of oncology indications. The Company's product candidates include Cantrixil (TRX-E-002-1), Anisina (ATM-3507) and Trilexium (TRX-E-009-1). The Company's target indication for Cantrixil is ovarian cancer, and Diffuse Intrinsic Pontine Glioma (DIPG) for Trilexium. The initial target pediatric indication for Anisina is neuroblastoma.Cantrixil (TRX-E-002-1)Cantrixil is the lead development candidate arising from its SBP technology. Cantrixil has been designed to be injected into the peritoneal cavity with the focus of inducing cell death in both differentiated cancer cells and cancer initiating cells, those cells thought to be primarily responsible for cancer recurrence post chemotherapy. The Company focuses on the Phase I study of intra-peritoneal Cantrixil to assess its pharmacokinetics in patients with refractory or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer.Anisina (ATM3507)Anisina is an approach to chemotherapy that targets the cancer cells' actin cytoskeleton. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KZIA     avg for
industry  
  avg for
sector  
42 stocks weight:  14. 13   217. 37   399. 45  
42 stocks rank:  3. 44 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  

quick ratio:  3. 50   5. 49   1. 88  
current ratio:  3. 63   5. 87   2. 36  

target price low:  4. 84   83. 44   114. 90  
target price avg:  4. 84   106. 20   137. 90  
target price high:  4. 84   132. 30   158. 97  
1-yr high:  3. 90   111. 86   142. 57  
last close:  2. 83   86. 79   125. 44  
50-day avg:  2. 84   86. 68   122. 63  
200-day avg:  3. 01   89. 22   121. 38  
1-yr low:  2. 20   69. 78   100. 51  
volume:  2. 36 K 2. 62 M 3. 43 M
50-day avg volume:  2. 52 K 3. 20 M 4. 16 M
200-day avg volume:  3. 77 K 2. 99 M 4. 75 M

1-day return:  5. 60 % -1. 30 % -0. 99 %
this week return:  -0. 64 % 0. 45 % -0. 20 %
12-wk return:  -19. 14 % 0. 94 % 4. 84 %
52-wk return:  -19. 61 % -1. 30 % 10. 55 %

enterprise value (EV):  17. 59 M 45. 10 B 122. 38 B
market cap:  15. 64 M 38. 96 B 108. 40 B

shares outstanding:  6. 22 M 538. 09 M 1. 24 B
shares:  3. 90 M 548. 00 M 1. 22 B
shares short:  2. 05 K 10. 98 M 11. 87 M
shares short prior month:  18. 00   9. 32 M 12. 05 M
short ratio:  0. 59   5. 60   3. 34  

book value:  2. 94   13. 35   27. 45  
price/book:  0. 96   4. 60   8. 78  
gross profits:  3. 00 M 7. 44 B 36. 13 B
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  100. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 92   2. 10   4. 23  
P/E:  -3. 08   1. 90   32. 10  
PE/G:  0. 07   0. 70   -0. 54  
growth:  -47. 00 % 265. 63 % 79. 11 %
earnings high:  -0. 00   0. 89   1. 68  
earnings avg:  -0. 00   0. 70   1. 57  
earnings low:  -0. 00   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -19. 09 % -2. 34 % 5. 28 %
return on equity:  -56. 61 % -90. 08 % 133. 53 %
revenue growth:  -47. 00 % 265. 25 % 73. 68 %

beta (1yr vs S&P500):  0. 14   1. 27   0. 91  
sharpe (1yr):  0. 18   0. 16   0. 77  

held % insiders:  0. 00 % 6. 06 % 3. 29 %
held % institutions:  1. 92 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : KZIA
.    101.393 =       101.393 :: --> INITIAL WEIGHT <--
.     - 0.92 =       100.473 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.052 =       206.209 :: P/E factor
.    x 1.977 =       407.692 :: PE/G factor
.    x 1.432 =       583.626 :: beta factor
.    x 0.702 =       409.535 :: sharpe factor
.    x 2.618 =      1072.342 :: current ratio factor
.    x 1.183 =      1268.523 :: quick ratio factor
.     x 1.72 =      2182.332 :: short ratio factor
.    x 1.005 =       2192.81 :: price-to-book factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4650.496 :: sector+industry 1-year gains factor
.    x 1.009 =      4694.341 :: industry 12-weeks return factor
.    x 1.308 =      6139.676 :: industry 2-weeks return factor
.    x 0.957 =      5873.021 :: "drift" penalty 3 days ago
.    x 0.992 =       5828.43 :: "drift" penalty 5 days ago
.     / 2.08 =       2801.48 :: overall "drift" factor
.    x 0.794 =      2223.691 :: largest single-day jump factor
.     x 0.07 =       154.961 :: low price factor
.    x 1.475 =       228.572 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.739 =       168.961 :: forward P/E factor
.    x 1.185 =        200.17 :: industry recommendation factor
.    x 1.003 =       200.724 :: factor historical industry gain for week 29
.   x 10.873 =      2182.504 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         6.835 :: reduced for readability
.    + 7.297 =        14.132 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     14.132 :: FINAL WEIGHT for NASDAQ:KZIA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org